Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Byrd

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Veterinary and Comparative Oncology|May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphomaR Mani, R Yan, X Mo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearanceJ C Byrd, J K Waselenko, T J Maneatis, et al.
The Journal of Biological Chemistry|December 5, 1991
Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian speciesJ R Gum, J W Hicks, R E Lagace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Leukemia|February 20, 2009
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphomaJ A Woyach, T S Lin, M S Lucas, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2010
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphismK A Blum, S-H Jung, J L Johnson, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry|March 15, 1993
Human gastric mucin. Identification of a unique species by expression cloningN W Toribara, A M Roberton, S B Ho, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Veterinary and Comparative Oncology|May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphomaR Mani, R Yan, X Mo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearanceJ C Byrd, J K Waselenko, T J Maneatis, et al.
The Journal of Biological Chemistry|December 5, 1991
Molecular cloning of rat intestinal mucin. Lack of conservation between mammalian speciesJ R Gum, J W Hicks, R E Lagace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Leukemia|February 20, 2009
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphomaJ A Woyach, T S Lin, M S Lucas, et al.
Blood|July 13, 2000
Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignanciesI W Flinn, J C Byrd, C Morrison, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2010
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphismK A Blum, S-H Jung, J L Johnson, et al.
Leukemia|April 29, 2005
Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemiaT S Lin, I W Flinn, M S Lucas, et al.
Blood|November 10, 1998
Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53J C Byrd, C Shinn, J K Waselenko, et al.
The Journal of Biological Chemistry|March 15, 1993
Human gastric mucin. Identification of a unique species by expression cloningN W Toribara, A M Roberton, S B Ho, et al.
Pageof 19